The main therapeutic goals for patients who have an acute coronary syndrome are to
reestablish normal epicardial flow and to increase distal myocardial perfusion. Fibrinolytic …

The main therapeutic goals for patients who have an acute coronary syndrome are to
reestablish normal epicardial flow and to increase distal myocardial perfusion. Fibrinolytic …

The main therapeutic goals for patients who have an acute coronary syndrome are to
reestablish normal epicardial flow and to increase distal myocardial perfusion. Fibrinolytic …

The most important therapeutic goal in the management of acute myocardial infarction is the
early restoration of complete epicardial infarct artery patency and normal myocardial …

Since the early 1980s, there has been a dramatic change in the management of acute
myocardial infarction, leading to a decrease in the death and complication rates for this …

Early reperfusion during myocardial infarction limits myocardial injury and reduces mortality.
Fibrinolysis (with streptokinase, or tissue or recombinant plasminogen activators) is today an …

The primary goals of the medical management of acute coronary syndromes are to restore
and to maintain coronary patency. Blood flow in totally occluded coronary arteries is restored …

The term acute coronary syndrome (ACS) refers to a spectrum of clinical conditions ranging
from acute myocardial infarction with ST elevation to minimally symptomatic myocardial …

An information sheet for patients appears at the end of the article. duced by recombinant
technology (rtPA), and when given as a bolus and step-down weight-adjusted infusion over …

Antithrombotic therapy is a major cornerstone in the treatment for acute coronary syndromes,
as thrombus formation upon a plaque rupture or an erosion plays a pivotal role in non-ST …